| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $408.5M | -3.9% |
| Cost of Revenue | $139.0M | +2.9% |
| Gross Profit | $269.5M | -7.1% |
| R&D Expense | $51.5M | -5.3% |
| SG&A Expense | $309.8M | -7.4% |
| Operating Income | -$126.2M | -27.1% |
| Pre-tax Income | -$112.3M | -14.8% |
| Income Tax | $1.1M | +119.4% |
| Net Income | -$113.4M | -23.0% |
| EPS (Basic) | -$3.06 | -19.5% |
| EPS (Diluted) | -$3.06 | -19.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.5M | -9.3% |
| Accounts Receivable | $71.9M | -9.4% |
| Inventory | $103.3M | -13.0% |
| Current Assets | $476.0M | -10.3% |
| Total Assets | $553.8M | -12.9% |
| Current Liabilities | $102.9M | +23.5% |
| Long-term Debt | $187.7M | -11.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | +67.0% |
| Capital Expenditures | $9.8M | +13.9% |
| Investing Cash Flow | $14.6M | +303.0% |
| Financing Cash Flow | -$4.2M | -108.5% |
| Free Cash Flow | -$29.2M | +56.7% |
| Total Liabilities |
| $322.8M |
| -5.8% |
| Stockholders' Equity | $231.0M | -21.2% |